178 related articles for article (PubMed ID: 33727054)
1. Mechanistic insights of snake venom disintegrins in cancer treatment.
Akhtar B; Muhammad F; Sharif A; Anwar MI
Eur J Pharmacol; 2021 May; 899():174022. PubMed ID: 33727054
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
Schönthal AH; Swenson SD; Chen TC; Markland FS
Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
[TBL] [Abstract][Full Text] [Related]
3. Disintegrins from snake venoms and their applications in cancer research and therapy.
Arruda Macêdo JK; Fox JW; de Souza Castro M
Curr Protein Pept Sci; 2015; 16(6):532-48. PubMed ID: 26031306
[TBL] [Abstract][Full Text] [Related]
4. [Potential use of snake venom components in cancer treatment].
Vivas D; Inga R; Yarlequé A
Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
[TBL] [Abstract][Full Text] [Related]
5. Anti-angiogenesis and RGD-containing snake venom disintegrins.
Swenson S; Ramu S; Markland FS
Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
[TBL] [Abstract][Full Text] [Related]
6. [Snake venom disintegrins: classification and therapeutic potential].
Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
[TBL] [Abstract][Full Text] [Related]
7. Snake Venom Disintegrins: An Overview of their Interaction with Integrins.
Cesar PHS; Braga MA; Trento MVC; Menaldo DL; Marcussi S
Curr Drug Targets; 2019; 20(4):465-477. PubMed ID: 30360735
[TBL] [Abstract][Full Text] [Related]
8. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
Kuo YJ; Chung CH; Huang TF
Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements of MLD-containing disintegrins for functional interaction with alpha 4 beta 1 and alpha 9 beta1 integrins.
Bazan-Socha S; Kisiel DG; Young B; Theakston RD; Calvete JJ; Sheppard D; Marcinkiewicz C
Biochemistry; 2004 Feb; 43(6):1639-47. PubMed ID: 14769041
[TBL] [Abstract][Full Text] [Related]
10. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
[TBL] [Abstract][Full Text] [Related]
11. Functional characteristic of snake venom disintegrins: potential therapeutic implication.
Marcinkiewicz C
Curr Pharm Des; 2005; 11(7):815-27. PubMed ID: 15777236
[TBL] [Abstract][Full Text] [Related]
12. Disintegrins.
McLane MA; Sanchez EE; Wong A; Paquette-Straub C; Perez JC
Curr Drug Targets Cardiovasc Haematol Disord; 2004 Dec; 4(4):327-55. PubMed ID: 15578957
[TBL] [Abstract][Full Text] [Related]
13. Applications of snake venom components to modulate integrin activities in cell-matrix interactions.
Marcinkiewicz C
Int J Biochem Cell Biol; 2013 Sep; 45(9):1974-86. PubMed ID: 23811033
[TBL] [Abstract][Full Text] [Related]
14. The continuing saga of snake venom disintegrins.
Calvete JJ
Toxicon; 2013 Feb; 62():40-9. PubMed ID: 23010163
[TBL] [Abstract][Full Text] [Related]
15. How snake venom disintegrins affect platelet aggregation and cancer proliferation.
Kolvekar N; Bhattacharya N; Sarkar A; Chakrabarty D
Toxicon; 2023 Jan; 221():106982. PubMed ID: 36435228
[TBL] [Abstract][Full Text] [Related]
16. The Role of Snake Venom Disintegrins in Angiogenesis.
Clissa PB; Della-Casa MS; Zychar BC; Sanabani SS
Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535794
[TBL] [Abstract][Full Text] [Related]
17. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
[TBL] [Abstract][Full Text] [Related]
18. Non-RGD-containing snake venom disintegrins, functional and structural relations.
Walsh EM; Marcinkiewicz C
Toxicon; 2011 Sep; 58(4):355-62. PubMed ID: 21801741
[TBL] [Abstract][Full Text] [Related]
19. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
Swenson S; Costa F; Ernst W; Fujii G; Markland FS
Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
[TBL] [Abstract][Full Text] [Related]
20. Snake venom disintegrins and cell migration.
Selistre-de-Araujo HS; Pontes CL; Montenegro CF; Martin AC
Toxins (Basel); 2010 Nov; 2(11):2606-21. PubMed ID: 22069567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
